Relation between Body Iron Store and Insulin Resistance in Type 2 Diabetes

Main Article Content

Wafa F. AL-Tai
Inaam A. Mohammed
Mayada S. Sabri

Abstract

The clinical impact of interaction between body iron status (serum iron and ferritin ) and type 2  diabetes  has been investigated in this study . Thirty six females were enrolled, eighteen type 2 diabetes and eighteen apparently healthy. These two groups were matched for age and body mass index BMI. The eighteen diabetes females were matched for age, BMI, pharmacological treatment (oral hypoglycemic agent), and chronic diabetes complications .


The biochemical parameters measured for both groups (control and diabetes patient) were fasting insulin(Io),fasting  blood glucose (Go) , serum iron and ferritin .


 A significant increase in all parameters in patients compared to healthy control was noticed . The insulin resistance ( IR) which was calculated by the equation:-


           IR= (Io µIU/ ml × Go mmol/ L)/22.5 was clearly demonstrated to be significantly higher in female diabetes patient( 275.9 ± 22.7) compared to control (41.5±11.3) .


 

Article Details

How to Cite
1.
Relation between Body Iron Store and Insulin Resistance in Type 2 Diabetes. Baghdad Sci.J [Internet]. 2010 Dec. 5 [cited 2024 Dec. 4];7(4):1395-9. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/11934
Section
article

How to Cite

1.
Relation between Body Iron Store and Insulin Resistance in Type 2 Diabetes. Baghdad Sci.J [Internet]. 2010 Dec. 5 [cited 2024 Dec. 4];7(4):1395-9. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/11934

References

Murray, R.K. Granner,D.K. Mayes,P.A. and Rodwell, V.W. 2006. Harper’s illustrared Biochemistry, 27th ed. McGraw Hill Companies, New York. pp 619.

Tsilchorozidou,T. Overton, C. and Conway G.S. 2004. Pathophysiology olycystic ovarian syndrome, Clin. Endocrinol. 60(1): 1-17 .

William,T.C. 2001. Minireview, Insulin resistance cellular and clinical concepts, Experimental biology and Medicine. 226:13-26.

McGarry, J.D. 2002. Dysregulation of fatty acid metabolism in etiology of type 2 diabetes. 51(1): 7-18.

Finch, C. 1994. Regulators of iron balance in humans, Blood. 84:1697-1702.

McCane R.A. and Widdowson , E.M. 1998 . The absorption and excretion of iron, J.phys. 94:148.

Tuomainen,T.P. Nyysonen, K. Saonen, R. Tervahauta, A. Korpela, H.and Lakka, T. 1997. Body iron stores are associated with serum insulin and blood glucose concentration, Diabetes Care. 20: 426-428.

Tanner, L.1.and Lienhard, G.E. 1989. Localization of Transfeerin receptors and insulin- like growth factorII receptors in vesicle from 3T3-L1 adipocyte that contain intracellular glucose transporters, J.Cell Biol. 108:1537-1545.

Niederau, C. Berger, M. Stremmel,W. Strake, A. Strohmeryer, G.and Ebert, R. 1984. Hyperinsulimia in non-cirrhotic haemchromatosis: impaired hepatic insulin degredation, Diabetologia. 26:441- 444.

Dennis,L.K. Eugene, B. Anthony,S.F. Stephan , H. and Dan, L.L. 2005. Harrison’s principles of Internal Medicine, Volume 1. 16th Ed. McGraw-Hill, Medical Publishing Division. pp 423-425.

Barham, D. and Trindoer, P. 1972. An improved color reagent from the determination of blood glucose by the oxidative system , Analyst. 97:142-145.

Nakogawa, S. Nakayama, H.and Sasaki, T. 1973. A simple method for determination of serum free insulin levels in insulin-treated patients, Diabetes. 22:590-600.

William, T.C. 2001. Insulin resistance: cellular and clinical concepts, Experimental Biology and Medicine, 226:13-26.

Henry, H.B. 1984. Clinical Diagnosis and Management by Laboratory Methods, Philadelphia, W.B. Saunders. USA .pp 1434 .

Voet,D. and Voet,J.G. 2004. Biochemistry. John Willyandsons Inc. 3rded .USA. pp 1066

Fernandez-Real, T.M. Ricart, W. Arroyo, E. Balance, R. Casamitjana, R.and Cabrero, D. 1998. Serum ferritin as a component of the insulin resistance syndrome, Diabetes Care 21:62-68.

Jorgen,J. Tine,W.H. Susanne,R.and Hans,I. 2007. Clinical research: Metabolic syndrome and risk . Insulin resistance, the metabolic, and risk of incident cardiovascular disease, J.Am. Coll cardiol; 49:2112-2119.

George, L.B. 2007. Current perspectives on hypertension and metabolic syndrome, Supplement to Journal of Managed Care Pharmacy JMCP. 13(5):4-5.

Juckett, M.B. Balla, J. Balla, G. Jessurun, J. Jacob, HS.and Vercellotti, GM. 1995. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro, Am.J. Pathol .147:782-789.

O'Beien, T. Basset, B. Burray, D.M. Dinneen, S.and O'Sulivan, D.J. 1990. Usefulness of biochemical osis, Diabetes Care. 532-534.

Mann, N. 2000. Dietary lean red meat and human evolution, Eur. J. Nutr. 39: 71-79

Similar Articles

You may also start an advanced similarity search for this article.